简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-03-20 10:19 Philip Morris International Announces Projects Selected in Second Funding Round of PMI IMPACT; $21 Million Awarded For Programs to Tackle Illegal Trade and Related Crimes
2019-03-19 17:57 SpeeDx Distribution Network Expands to the Middle East
2019-03-19 13:57 SpinalCyte to Present at China Focus @ Europe Vienna
2019-03-19 10:11 Boehringer Ingelheim announces FDA and EMA regulatory submission for nintedanib in systemic sclerosis associated ILD
2019-03-18 18:08 Japanese Startups Aim to Solve Consumer and Societal Challenges with New Technologies Demonstrated at SXSW 2019
2019-03-18 11:57 HKTDC Hong Kong International Medical and Healthcare Fair Presents Leading-Edge Medical Products and Unveils Trends
2019-03-15 14:44 Octapharma Group Reports Strong Results for 2018
2019-03-15 10:17 OncoImmunity Becomes the First Company to Obtain the CE-IVD Mark for Clinical Use of a Machine-Learning Based Neoantigen Prediction Technology
2019-03-15 10:05 PMI’s Latest Study Indicates E-Cigarettes Induce Less Biological Responses Associated with Cardiovascular and Pulmonary Diseases Than Cigarettes
2019-03-15 10:01 Medicalbit Foundation Co., Ltd. To Make ASCA Tokens Public
2019-03-14 17:36 Flow Pharma, Inc. and OncoImmunity AS partner for the Development of FlowVaxTM Personalized Cancer Vaccines
2019-03-14 17:32 BCW Wins 2019 Artificial Intelligence Excellence Award
2019-03-14 13:36 Mary Kay Reveals Latest Research at the 20th World Dermatology Congress
2019-03-14 10:02 Harvest Health & Recreation to Acquire Verano, Creating One of the Largest U.S. Multi-State Cannabis Operators
2019-03-12 18:08 Dental Monitoring Partners with Vitruvian to Accelerate Global Expansion of Its Innovative AI Solutions
2019-03-12 09:47 Celgene Submits Application to EMA for Ozanimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
2019-03-11 10:11 Vedolizumab (Entyvio®) Achieves Superior Rates of Clinical Remission vs. Adalimumab (Humira®) in First Ever Head-to-Head Biologic Clinical Study in Ulcerative Colitis
2019-03-11 10:06 New ESMO Guidelines Include FOTIVDA®▼(tivozanib) Recommendation for Patients with Advanced Renal Cell Carcinoma
2019-03-11 10:03 Galderma Presented Final Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting Late-Breaking Session
2019-03-08 20:00 Vitruvias Therapeutics Inc. Launches Shanghai-Based Sinotherapeutics’s Approved Version of Propafenone ER in the U.S.

Business Wire Weibo

Press Releases

Latest Releases